Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02924376
Status:
COMPLETED
Last Update Posted:
2023-02-23
First Post:
2016-10-04
Brief Title:
Efficacy and Safety of Pemigatinib in Subjects With AdvancedMetastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - FIGHT-202
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Organization Data
Organization:
Incyte Corporation
Class:
INDUSTRY
Study ID:
INCB 54828-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Incyte Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None